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The fimbriae of Porphyromonas gingivalis mediate critical roles in host colonization and evasion of innate
defenses and comprise polymerized fimbrilin (FimA) associated with quantitatively minor accessory proteins
(FimCDE) of unknown function. We now show that P. gingivalis fimbriae lacking FimCDE fail to interact with
the CXC-chemokine receptor 4 (CXCR4), and bacteria expressing FimCDE-deficient fimbriae cannot exploit
CXCR4 in vivo for promoting their persistence, as the wild-type organism does. Consistent with these loss-
of-function experiments, purified FimC and FimD (but not FimE) were shown to interact with CXCR4.
However, significantly stronger binding was observed when a combination of all three proteins was allowed to
interact with CXCR4. In addition, FimC and FimD bound to fibronectin and type 1 collagen, whereas FimE
failed to interact with these matrix proteins. These data and the fact that FimE is required for the association
of FimCDE with P. gingivalis fimbriae suggest that FimE may recruit FimC and FimD into a functional
complex, rather than directly binding host proteins. Consistent with this notion, FimE was shown to bind both
FimC and FimD. In summary, the FimCDE components cooperate and impart critical adhesive and virulence
properties to P. gingivalis fimbriae.
Bacterial fimbriae (also referred to as pili) are key players in
host-pathogen interactions by mediating colonization and fa-
cilitating establishment of infection (16). These filamentous
appendages extend to a significant distance from the bacterial
cell surface (up to several micrometers) and may thus be the
first molecules to interact with the host in an attempt to initiate
infection. Fimbriae function as critical colonization factors also
for certain oral pathogens, including Porphyromonas gingivalis
(11). This is a gram-negative anaerobic bacterium that is
strongly associated with periodontal disease (19) and is, more-
over, implicated in certain systemic inflammatory conditions,
such as atherosclerosis (18). To date, two types of P. gingivalis
fimbrial structures have been described. These comprise the
so-called “major” (or “long”) fimbriae encoded by the fimA
gene (2) and the “minor” (or “short”) fimbriae encoded by the
mfa1 gene (23).
The P. gingivalis “major” fimbriae (henceforth referred to as
simply “fimbriae”) have been studied in greater molecular de-
tail, and their role in virulence was established in rodent mod-
els of periodontitis and atherosclerosis (3, 13). Although the
fimbriae are traditionally recognized for their adhesive affinity
for various dental or epithelial substrates and extracellular
matrix proteins (1, 4, 20), they have more recently been impli-
cated in subversion of host immune function (7, 24). For ex-
ample, we have shown that the fimbriae bind the CXC-
chemokine receptor 4 (CXCR4), which in turn cross talks
with and suppresses the Toll-like receptor 2 (TLR2) signal-
ing pathway, leading to enhanced P. gingivalis persistence in
vitro and in vivo (7).
Although the fimbrilin subunit (FimA) constitutes the main
structural component of P. gingivalis fimbriae, it is now appre-
ciated that the native fimbrial structure contains additional
protein components, encoded by genes immediately down-
stream of fimA (15, 24, 26). These accessory proteins, namely
FimC, FimD, and FimE (with molecular masses of 50, 80, and
60 kDa, respectively), comprise 1% of the fimbrial protein
content but, strikingly, appear to contribute significantly to P.
gingivalis virulence (24, 26). Specifically, we have shown that P.
gingivalis isogenic mutants expressing FimA fimbriae devoid of
all three accessory proteins (designated DAP fimbriae) are
dramatically less virulent than the parent strain in the mouse
periodontitis model (24).
Since DAP fimbriae display diminished binding to certain
extracellular matrix proteins (fibronectin and type I collagen)
(15), the attenuated virulence of the FimCDE-deficient mu-
tants could be attributed, at least partly, to decreased potential
for colonization. However, these mutants exhibit additional
differences compared to wild-type P. gingivalis, including in-
creased capacity to activate transcription factor NF-B (24).
Given that increased microbial activation of NF-B-dependent
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host defense may impede microbial persistence in the host
(14), we speculated that the FimCDE-deficient mutants elicit
robust host responses that contribute to their elimination (24).
The concept that increased NF-B activation may impair P.
gingivalis persistence was demonstrated in a subsequent study
by our group. Specifically, antagonistic blockade of the P. gin-
givalis fimbria-CXCR4 interaction abrogated induction of cy-
clic AMP (cAMP)-dependent negative regulatory signals, lead-
ing to enhanced TLR2-mediated NF-B activation and nitric
oxide production, which inhibited the persistence of the patho-
gen (7).
Since CXCR4 negatively regulates the innate response to
wild-type P. gingivalis (7), and the FimCDE-deficient mutants
are more immunostimulatory than the wild-type organism (24),
we hypothesized that DAP fimbriae (i.e., containing FimA but
lacking FimCDE) may fail to interact with CXCR4. If correct,
the implication of this hypothesis would be that one or more of
the FimCDE accessory molecules may interact directly with
CXCR4. By the same rationale, since DAP fimbriae fail to bind
fibronectin and type I collagen (15), these activities may be
mediated by at least one of the accessory fimbrial components.
Alternatively, DAP fimbriae may be conformationally different
from wild-type fimbriae in a way that interactions with certain
host molecules are negatively affected. In this paper, we ad-
dressed two major hypotheses: (i) the increased potential of
DAP fimbriae for cell activation (relative to the wild type) is
attributed to reduced reactivity with CXCR4, and (ii) one or
more of the FimCDE components are directly involved in the
interactions of P. gingivalis fimbriae with CXCR4 and other
host proteins. Our conclusion from these studies is that the
accessory FimCDE proteins endow P. gingivalis fimbriae with
additional adhesive and virulence properties, over and above
those described for the isolated FimA subunit (reviewed in
references 1 and 4).
MATERIALS AND METHODS
Reagents and bacteria. Monoclonal antibodies (MAbs) to CXCR4 (clone
12G5), TLR2 (TL2.1), and isotype controls were purchased from e-Bioscience.
MAbs to major histocompatibility complex (MHC) class I (W6/32) and CD14
(Tu¨k 4) were from Abcam. Cholera toxin B subunit was from List Biological Labs
and was used to label GM1 ganglioside in fluorescent resonance energy transfer
(FRET). For FRET (described below), MAbs or cholera toxin B subunit were
conjugated to Cy3 or Cy5 using labeling kits from Amersham Biosciences.
AMD3100 and methyl--cyclodextrin (MCD) were from Sigma-Aldrich.
P. gingivalis ATCC 33277 and its isogenic mutant OZ5001C were grown anaer-
obically at 37°C in hemin- and menadione-containing GAM medium (Nissui
Pharmaceutical) (24), and their fimbriae were extracted and chromatographically
purified as previously described (27). The P. gingivalis fimC, fimD, and fimE
genes were PCR amplified using chromosomal DNA as template and the oligo-
nucleotide primers shown in Table 1. Recombinant plasmids encoding His-
tagged versions of FimC, FimD, and FimE (respectively termed pSN141,
pSN142, and pSN140) were constructed by cloning the corresponding amplified
genes into the pET200 expression vector using the Champion pET directional
TOPO expression kit (Invitrogen). The primers were designed so that the am-
plified gene regions would encode the mature forms of FimC, FimD, and FimE
(the amino acid residue numbers are indicated in Table 1). Recombinant His-
tagged FimC, FimD, and FimE were purified from cell lysates of transformed
Escherichia coli BL21 Star(DE3) by Cu2 affinity chromatography using a
HiTrap chelating HP column, according to the manufacturer’s instructions (GE
Healthcare). When necessary, protein preparations were passed through a col-
umn of agarose-immobilized polymyxin B (Pierce) to remove residual lipopoly-
saccharide (LPS). Purified native or recombinant fimbrial preparations were free
of any contaminating substances on sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and contained negligible endotoxin (8 endotoxin units [EU]/
mg), as determined by the Limulus amebocyte lysate assay (BioWhittaker).
Polyclonal antibodies to FimC, FimD, or FimE were raised in immunized rabbits
as previously described (27). All reagents were used at optimal concentrations
determined in preliminary or published studies by our laboratories (5, 7, 15, 22).
Mammalian cell culture and transfections. Monocytes were purified from
human A buffy coats by means of centrifugation over NycoPrep1.068 (Axis-
Shield) as previously described (22) and were cultured at 37°C and 5% CO2 in
RPMI 1640 (InVitrogen) supplemented with 10% heat-inactivated fetal bovine
serum, 2 mM L-glutamine, 10 mM HEPES, 100 U/ml penicillin G, 100 g/ml
streptomycin, and 0.05 mM 2-mercaptoethanol. The same medium was used to
culture human monocytic THP-1 cells (ATCC TIB 202). Chinese hamster ovary
(CHO)-K1 cells (ATCC CRL-9618) were maintained in Ham’s F-12 nutrient
mixture (InVitrogen) containing 2 mM L-glutamine, 10% heat-inactivated fetal
bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin. CHO-K1 cells
were transfected with empty vector control or human CXCR4 (pORF-hCXCR4;
InVivogen) using the PolyFect transfection reagent (Qiagen) or Lipofectamine
2000 (InVitrogen) (7, 22). Cell viability was monitored using the CellTiter-Blue
assay kit (Promega), and none of the treatments affected cell viability compared
to that of the medium-only control.
FRET. FRET can determine sterical coassociation of fluorescently labeled
receptors on the basis of measurements of nonradiative energy transfer from the
excited state of a donor molecule to an appropriate acceptor (25) and was
performed as previously described (5, 21). Briefly, upon stimulation of human
monocytes for 10 min at 37°C with P. gingivalis wild-type or DAP fimbriae (1
g/ml) or the medium-only control, the cells were labeled with a mixture of
Cy3-conjugated MAb (donor) and Cy5-conjugated MAb (acceptor), as indicated
in Fig. 2. The cells were washed and fixed, and energy transfer between different
receptor pairs was calculated from the increase in donor fluorescence after
acceptor photobleaching.
FCS. The fluorescence correlation spectroscopy (FCS) method is based on
autocorrelation analysis of fluorescence intensity fluctuations, which are confo-
cally detected when fluorescent ligands diffuse through a minute (0.2 fl) excita-
tion volume known as the confocal volume element (17). FCS was performed
using a ConfoCor instrument (Carl Zeiss) equipped with a Zeiss Neofluar 40,
numerical aperture 1.2 objective. The technique was used to obtain the diffusion
time constants of free and receptor-bound fluorescein isothiocyanate (FITC)-
labeled fimbriae (wild type or DAP) interacting with CXCR4-expressing CHO
cells. The diffusion time constants were derived from the analysis of fluorescence
TABLE 1. Primers used to PCR amplify P. gingivalis fim genes
Primer Gene Direction 533 sequencea Cloned genesequence
Corresponding
residuesb
NSN244 fimC Forward CACCGGCGGAGACCTCTACAGTGG 169–1359 57–453
NSN245 fimC Reverse TTAAAGTCCTTGTTGTATGATC
NSN247 fimD Forward CACCGAAGACATAGAGTCCGATATG 82–2010 28–670
NSN248 fimD Reverse TCATTTCTTCAGTCTTTTTGC
NSN242 fimE Forward CACCGTAAGCGGTAGCATTGTTTC 112–1650 38–550
NSN243 fimE Reverse CTAATTCGTCACGTGAATCG
a Underlined extra sequences (CACC) were added so that the coding sequences of the amplified DNA segments be inserted in frame into the pET200 vector.
b Corresponding amino acid sequences encoded by the cloned genes.
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intensity fluctuations with autocorrelation functions, computed in real time by a
digital signal correlator in the ConfoCor instrument, as previously described
(22).
Intermolecular interactions of fimbrial proteins. Polystyrene microtiter plates
(96-well Maxisorp; Nunc) were coated with 100 l of 250 nM FimE in phosphate-
buffered saline (PBS), pH 7.2, at 4°C overnight. The plates were washed with
PBS containing 0.05% (vol/vol) Tween 20, and nonspecific binding sites were
blocked with 5% (wt/vol) bovine serum albumin (BSA) in PBS for 1 h at room
temperature. After further washing, 100 l of 62.5 to 250 nM of FimC, FimD, or
both was added and the mixture was incubated at 4°C overnight. The plates were
then washed, and bound proteins were detected with specific rabbit immuno-
globulin G (IgG) antibodies to FimC or FimD (at 1:64,000 or 1:32,000 dilution,
respectively) followed by peroxidase-conjugated goat-anti rabbit IgG antibody.
Following a final washing, tetramethylbenzidine substrate was added, the chro-
mogenic reaction was stopped with 0.5 M H2SO4, and the generated optical
density signal at 450 nm (OD450) was read in a microplate reader. Optimal
antibody dilutions were determined in preliminary experiments, in which it was
also confirmed that anti-FimC and anti-FimD do not recognize the coating
protein (FimE) or the reciprocal protein used as ligand (e.g., anti-FimC fails to
bind FimD). Moreover, both antibodies failed to bind to plates coated with
recombinant His-tagged glyceraldehyde-3-phosphate dehydrogenase, suggesting
that the antibodies do not recognize the poly-histidyl tag fusion partner of the
proteins used in the assay.
Binding of fimbrial proteins to host proteins. The binding of FimC, FimD, and
FimE to fibronectin and type I collagen was assessed essentially as previously
described for native fimbriae (15), with minor modications. Briefly, fibronectin-
or type I collagen-precoated microplates (Becton Dickinson Labware) were
treated with 1% (wt/vol) BSA in PBS to block nonspecific binding sites and were
then incubated with 50 or 100 nM FimC, FimD, or FimE at 4°C overnight,
followed by washing with PBS–0.05% Tween 20. All three proteins are His
tagged, and since these assays involved adding a single fimbrial protein in the
wells, detection of bound protein was carried out by using peroxidase-conjugated
anti-His antibody, followed by addition of tetramethylbenzidine chromogenic
substrate. The optical density signal at 450 nm was read in a Bio-Rad microplate
reader.
The binding of purified fimbrial proteins of P. gingivalis to transfected cell lines
was determined using a fluorescent cell-based assay in 96-well plates as we
previously described (6, 8). Briefly, biotinylated wild-type or DAP fimbriae (1
g/ml) or recombinantly expressed FimC, FimD, or FimE was incubated with
empty vector-transfected or CXCR4-transfected CHO cells (7). Specific binding
to CXCR4 was controlled by including in the assays the CXCR4-specific antag-
onist AMD3100. The proteins were allowed to bind for 30 min at 37°C, and after
washing, bound proteins were probed with FITC-labeled streptavidin. Upon
further washing, binding was determined by measuring cell-associated fluores-
cence on a microplate fluorescence reader (FL600; Bio-Tek Instruments) with
excitation/emission wavelength settings of 485/530 nm. FimC, FimD, and FimE
were used at 0.1 to 10 g/ml in preliminary experiments and at 20 nM (1 to 1.5
g/ml depending on molecular weight) in the presented experiments.
Intracellular cAMP induction. Levels of cAMP in activated cell extracts were
measured using a cAMP enzyme immunoassay kit (Cayman) (12).
P. gingivalis in vivo infection. Specific-pathogen-free BALB/cByJ mice (8 to 10
weeks old; Jackson Labs) were pretreated intraperitoneally (i.p.) with AMD3100
(25 g in 0.1 ml PBS) or PBS alone. After 1 h, the mice were infected i.p. with
P. gingivalis 33277 or OZ5001C (5  107 CFU). Peritoneal lavage was performed
20 h and 48 h postinfection. Serial 10-fold dilutions of peritoneal fluid were
plated onto blood agar plates and cultured anaerobically at 37°C for enumeration
of recovered peritoneal CFU. All animal procedures were approved by the
Institutional Animal Care and Use Committee and performed in compliance
with established federal and state policies.
Statistical analysis. Data were evaluated by analysis of variance and the
Dunnett multiple-comparison test using the InStat program (GraphPad Soft-
ware). Where appropriate (comparison of two groups only), unpaired two-tailed
t tests were performed. P  0.05 was taken as the level of significance. All
experiments were performed at least twice, yielding consistent results.
RESULTS
Fimbriae lacking FimCDE are impaired in CXCR4 binding
and induction of CXCR4-TLR2 coassociation. Using human
monocytes or mouse macrophages, we have previously shown
that DAP fimbria-expressing P. gingivalis (strain OZ5001C) is
significantly more proinflammatory than the wild-type organ-
ism (strain 33277), and similar differences were seen between
their respective isolated fimbriae (5, 24). However, similar to
wild-type fimbriae, DAP fimbriae also depend upon CD14
and TLR2 for cell activation (5, 24). Since CXCR4 is a
negative regulator of wild-type fimbria-induced CD14-TLR2-de-
pendent signaling (7), we hypothesized that DAP fimbriae may
not efficiently interact with CXCR4. We thus compared the
CXCR4 binding activities of wild-type and DAP fimbriae. Trans-
fection of CHO-K1 cells with CXCR4 (CHO-CXCR4 cells) re-
sulted in high-level binding of wild-type fimbriae, which was ab-
rogated by anti-CXCR4 MAb (but not by the isotype control) or
by a specific CXCR4 antagonist (AMD3100) (Fig. 1). In con-
trast, DAP fimbriae displayed poor CXCR4-binding activity,
being 30% of that seen with wild-type fimbriae (P  0.05,
Fig. 1).
These data were consistent with subsequent FCS analysis, a
biophysical method that can determine the dynamics of ligand-
receptor interactions. In FCS, receptor-bound and freely dif-
fusing ligands are distinguished by their characteristic diffusion
time constants (D), since receptor-ligand complexes diffuse
relatively slow in the plane of the cell membrane. We initially
examined the diffusion characteristics of FITC-labeled wild-
type or DAP fimbriae using control CHO cells, and the analysis
in either case revealed a simple monophasic autocorrelation
curve with D	 59
 1.1 ms and D	 58
 0.5 ms, respectively
(Table 2). The existence of a single diffusion time component
for either type of fimbriae indicated that neither molecule
engaged in receptor interactions and, therefore, the diffusion
times observed likely correspond to freely diffusing unbound
molecules. In contrast, FCS measurements taken on the cell
membrane of CHO-CXCR4 cells produced autocorrelation
functions containing two diffusion components. In the case of
wild-type fimbriae, the mean diffusion times were 66 
 1.8 ms
(D1) and 150 
 20 ms (D2) (Table 2). The fast-diffusing
component (D1) is comparable to that seen with wild-type
fimbriae incubated with control CHO cells and corresponds to
unbound fimbriae, whereas the slow-diffusing component (D2)
is attributable to the presence of CXCR4 and corresponds to
FIG. 1. Comparison of wild-type (WT) and DAP fimbriae in
CXCR4 binding. CXCR4-transfected CHO-K1 cells were incubated
with biotinylated WT or DAP fimbriae (1 g/ml), with or without
CXCR4 inhibitors (5 g/ml anti-CXCR4 MAb or 1 g/ml AMD3100).
Binding was measured in relative fluorescence units (RFU) after stain-
ing with streptavidin-FITC. Background binding to empty vector-trans-
fected cells (3,691
 298 RFU) is indicated by a horizontal dashed line.
Data are means 
 standard deviations (n 	 3). Asterisks indicate
significant (P  0.05) differences between WT and DAP fimbriae.
Inverted triangles show significant (P  0.05) inhibition of binding by
CXCR4 inhibitors.
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bound fimbriae. FCS analysis of the binding of DAP fimbriae
to CHO-CXCR4 cells also revealed two components with dif-
fusion times of 62 
 1.2 ms (D1; free ligand) and 80 
 10 ms
(D2; bound ligand) (Table 2). The observation that bound
wild-type fimbriae exhibit a significantly slower diffusion time
than bound DAP fimbriae (P  0.05) (Table 2) suggests that
the wild-type molecule interacts more strongly with CXCR4, in
accordance with the results from the binding study (Fig. 1).
The instigation of an inhibitory CXCR4-TLR2 cross talk by
wild-type fimbriae is dependent upon their ability to induce
CXCR4-TLR2 coassociation in lipid rafts (7). We have now
found that DAP fimbriae are inefficient in this activity. Indeed,
FRET analysis showed that the energy transfer between TLR2
and CXCR4 in DAP fimbria-activated monocytes was signifi-
cantly less than that in wild-type fimbria-activated cells (P 
0.05) (Fig. 2A). In contrast, wild-type and DAP fimbriae were
similarly effective in inducing CD14-TLR2 coassociation (Fig.
2A). No coassociation was observed between TLR2 and MHC
class I (negative control) in cells activated with either type of
fimbriae (Fig. 2A). Cell pretreatment with the lipid raft-dis-
rupting agent MCD abrogated the energy transfer between
TLR2 and CXCR4 or between TLR2 and CD14 regardless of
stimulus (Fig. 2A), consistent with previous observations that
these interactions take place in lipid rafts (7). Therefore, the
increased potential of DAP fimbriae for cell activation (5, 24)
may be due to activation of TLR2 with minimal CXCR4 in-
terference. Alternatively or additionally, it could be argued
that DAP fimbriae induce lipid raft recruitment of TLR2 at
higher levels than wild-type fimbriae; however, this notion was
ruled out by showing that both types of fimbriae induce similar
association of TLR2 with the lipid raft marker GM1 ganglio-
side (Fig. 2B). In short, DAP fimbriae are relatively weak in
inducing TLR2-CXCR4 association and binding CXCR4 (Fig.
1 and 2 and Table 2), thereby allowing unimpeded TLR2
activation compared to wild-type fimbriae.
FimCDE-deficient P. gingivalis displays reduced persistence
in vivo. We previously showed that wild-type P. gingivalis ex-
ploits CXCR4 for enhancing its persistence in a mouse i.p.
infection model (7). We have now addressed whether an iso-
genic mutant that expresses DAP fimbriae (strain OZ5001C)
displays reduced interaction with CXCR4 and persistence in
vivo, in comparison with the wild-type strain, 33277. At 20 h
postinfection, the recovery of the OZ5001C mutant (viable
CFU counts) from the peritoneal cavity of PBS-pretreated
mice was 25-fold lower than that of the wild-type strain, 33277
(P  0.05) (Fig. 3A). As expected from our previous study (7),
mouse pretreatment with AMD3100 resulted in dramatically
reduced recovery of viable CFU counts of 33277 (P  0.05)
(Fig. 3A). In stark contrast, however, the recovery of viable
OZ5001C CFU was not significantly affected by AMD3100
(Fig. 3A). In a second experiment, the observations were ex-
tended to 48 h postinfection, at which time the OZ5001C
mutant was not recoverable in a viable state (Fig. 3B). In
contrast, the 33277 wild-type strain persisted in a viable state
for 48 h, although its recovery was again significantly reduced
by CXCR4 blockade (P 0.05) (Fig. 3B). Therefore, wild-type
P. gingivalis (i.e., expressing FimCDE-containing fimbriae) ap-
pears to exploit CXCR4 in vivo resulting in dramatically
enhanced persistence in the mouse host compared to the Fim-
CDE-deficient strain.
Interactions of FimCDE accessory proteins with host mol-
ecules. The findings that wild-type fimbriae interact with
CXCR4 considerably more efficiently than DAP fimbriae sug-
gest that one or more of the fimbrial accessory proteins may
bind CXCR4. Indeed, purified FimC and FimD exhibited low
but statistically significant (P  0.05) binding to CXCR4,
whereas FimE failed to interact (Fig. 4). However, strong bind-
ing, comparable to that of wild-type fimbriae, was observed
when FimC was allowed to interact with CHO-CXCR4 cells in
TABLE 2. Diffusion times obtained by FCS analysis of wild-type or
DAP fimbriae binding to CXCR4
Cells Ligand
Diffusion
time
component
Diffusion
time (ms)a
CHO (control) Wild-type fimbriae D 59 
 1.1
DAP fimbriae D 58 
 0.5
CHO-CXCR4 Wild-type fimbriae D1 66 
 1.8
D2 150 
 20*
DAP fimbriae D1 62 
 1.2
D2 80 
 10
a FCS measurements were performed in living CHO-CXCR4 or control CHO
cells using FITC-labeled wild-type or DAP fimbriae. The diffusion times were
derived from the analysis of fluorescence intensity fluctuations with autocorre-
lation functions. Data are means 
 standard deviations (n 	 6). , significantly
(P  0.05) different versus the corresponding diffusion time component (D2) of
DAP fimbriae.
FIG. 2. Wild-type (WT) versus DAP fimbriae in inducing TLR2-CXCR4 association. Monocytes were stimulated with 1 g/ml WT or DAP
fimbriae for 10 min, with or without 10 mM MCD pretreatment. Energy transfer between TLR2 (Cy3) and CD14 (Cy5), CXCR4 (Cy5), or MHC
class I (Cy5) (A) or between TLR2 (labeled with Cy3) or MHC class I (Cy3) and the lipid raft marker GM1 (Cy5) (B) was measured from the
increase in donor (Cy3) fluorescence after acceptor (Cy5) photobleaching. Results are means 
 standard deviations (n 	 3). Asterisks show
significant increase in energy transfer (P  0.05 versus unstimulated cells). Inverted triangles show significant differences (P  0.05) between WT
and DAP fimbriae.
VOL. 77, 2009 P. GINGIVALIS FimCDE-HOST INTERACTIONS 3297
 o
n
 February 24, 2014 by Cardiff Univ
http://iai.asm
.org/
D
ow
nloaded from
 
the concomitant presence of both FimD and FimE (P  0.05
versus binding of isolated components or DAP fimbriae) (Fig.
4). In the presence of AMD3100, the binding of FimCDE was
reduced to background levels, confirming specific involvement
of CXCR4 (Fig. 4). Therefore, FimCDE may cooperate for
enhanced CXCR4 binding. Consistent with this notion, the
combination of all three proteins, but not the individual com-
ponents, induced significant CXCR4-dependent elevation of
cAMP (P  0.05) (Fig. 5).
In sharp contrast to wild-type fimbriae, DAP fimbriae also
display negligible binding to certain matrix proteins (fibronec-
tin and type I collagen), implying that at least one of the
fimbrial accessory proteins may have a direct role (15). Al-
though FimE was inert in terms of CXCR4 binding activity
(Fig. 4), it could not be ruled out that FimE may be involved
in other types of interactions. We thus determined and com-
pared the binding activities of FimC, FimD, and FimE for
fibronectin and type I collagen. FimE again failed to bind
either matrix protein, although FimC and especially FimD
readily bound to both fibronectin (Fig. 6A) and type I collagen
(Fig. 6B). It should be noted that the lack of detection of FimE
by anti-His tag MAb cannot be attributed to possible inacces-
sibility of the His6 epitopes of this recombinant protein, since
we have confirmed that anti-His tag MAb readily detects FimE
(data not shown). These findings further support that FimC
and FimD confer important adhesive functions to P. gingivalis
fimbriae, although the precise role of FimE remained enig-
matic.
Intermolecular interactions of fimbrial accessory proteins.
Despite lacking direct binding activity for the host molecules
tested, the presence of FimE was important for maximal
CXCR4 interactions by FimCDE (Fig. 4 and 5). Moreover,
FimE-deficient P. gingivalis produces FimA fimbriae devoid of
all three accessory components (15). This suggests that FimE
may recruit FimC and FimD into a functional complex. To
address the notion that FimE recruits FimC and FimD, FimE
was used as the coating protein and FimC and FimD as po-
tential ligands in an enzyme-linked immunosorbent assay-
based binding assay. Highly specific anti-FimC and anti-FimD
antibodies (which were confirmed to lack cross-reactive activ-
ity) were used for probing bound FimC and FimD, respec-
FIG. 3. Reduced virulence and lack of CXCR4 exploitation by P. gingivalis expressing fimbriae devoid of FimCDE. BALB/cByJ mice were i.p.
pretreated with AMD3100 (25 g in 0.1 ml PBS) or PBS alone. After 1 h, the mice were i.p. infected with 5  107 CFU P. gingivalis 33277 or
OZ5001C (FimCDE-deficient isogenic mutant). Peritoneal lavage was performed 20 h (A) or 48 h (B) postinfection. Serial 10-fold dilutions of
peritoneal fluid were plated for anaerobic growth and enumeration of recovered CFU. Horizontal lines show mean CFU counts. Asterisks indicate
significant (P  0.05) differences in P. gingivalis peritoneal CFU due to AMD3100 pretreatment. Inverted triangles show significant differences
(P  0.05) between corresponding 33277 and OZ5001C CFU. NR, not recoverable in a viable state.
FIG. 4. Binding of FimCDE accessory proteins to CXCR4.
CHO-K1 cells transfected with empty vector or CXCR4 (in the ab-
sence or presence of 1 g/ml AMD3100) were incubated with biotin-
ylated wild-type (WT) or DAP fimbriae (1 g/ml) or with fimbrial
accessory proteins (20 nM of total protein, corresponding to 1 to 1.5
g/ml), alone or in the combinations indicated. Binding was measured
in relative fluorescence units (RFU) after staining with streptavidin-
FITC. In assaying the binding of FimC in the presence of FimD and/or
FimE, only FimC was used in the biotinylated form. Results are
means 
 standard deviations (n 	 3). The asterisks show significant
(P  0.05) binding versus empty vector-transfected cells. Inverted
triangles denote significant (P  0.05) inhibition of binding by
AMD3100. The black circle indicates significantly (P  0.05) higher
FimCDE binding compared to individual fimbrial accessory proteins
and DAP fimbriae.
FIG. 5. Induction of CXCR4-dependent cAMP responses by fim-
brial proteins. THP-1 cells were stimulated for 20 min with wild-type
(WT) or DAP fimbriae (1 g/ml) or with fimbrial accessory proteins
(20 nM of total protein, corresponding to 1 to 1.5 g/ml), alone or in
the combinations indicated. The stimulation was carried out in the
absence or presence of AMD3100, and the cells were assayed for
induction of intracellular cAMP. Results are means 
 standard devi-
ations (n 	 3). The asterisks indicate significant (P  0.05) elevation
of intracellular cAMP over basal levels (medium only). Inverted tri-
angles show significant (P  0.05) inhibition of cAMP responses by
AMD3100.
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tively. We found that both FimC (Fig. 7A) and FimD (Fig. 7B)
could bind immobilized FimE in a dose-dependent manner
(Fig. 7). The probing antibodies showed negligible reactivity
when BSA substituted for the specific ligands in the FimE-
coated wells. The binding of FimC to FimE was modestly but
significantly (P  0.05) reduced by the concomitant presence
of FimD in the assay volume (Fig. 7A), and vice versa (Fig.
7B). This might be explained by reduced epitope exposure of
bound FimC to the probing anti-FimC antibodies, perhaps due
to possible interactions of FimC with FimD (and vice versa).
This possibility is consistent with a subsequent observation that
FimD directly binds FimC. (The OD450 binding value was
0.36 
 0.01 versus 0.03 for nonspecific background binding.)
DISCUSSION
The molecular basis of the multifunctional adhesive ability
of P. gingivalis fimbriae has always been a puzzle. The results of
functional mapping studies suggest that the FimA sequence
contains several adhesion epitopes for distinct host molecules,
although certain epitopes involve versatile structural motifs
that are recognizable by more than one host protein (reviewed
in reference 4). However, given that the FimA-associated ac-
cessory proteins were not included in the earlier mapping stud-
ies, it is possible that a number of activities associated with P.
gingivalis fimbriae remained “uncharted territory.” Indeed, al-
though the fimbrial accessory proteins were first described
more than 15 years ago (28), it was only recently that their
function started to be elucidated. Whereas we previously ob-
tained only indirect evidence for the biological significance of
FimCDE (15, 24), we have now generated conclusive direct
evidence. For example, although previous studies revealed dra-
matic differences between wild-type and FimCDE-deficient
(DAP) fimbriae in terms of binding fibronectin or type I col-
lagen (15), a direct role for FimCDE was only now established
by showing that two of these proteins (FimC and FimD) bind
to these extracellular matrix proteins. Interestingly, electron
microscopic examination of P. gingivalis wild-type and DAP
strains has revealed that DAP fimbriae are structurally distinct
from wild-type fimbriae (24). However, the DAP fimbriae do
not show any intrinsic defects in their potential to interact with
innate receptors or to activate cells. Indeed, wild-type and
DAP fimbriae interact equally well with TLR2 and CD14,
although DAP fimbriae are more proinflammatory (24), owing
to their relative inability to efficiently interact with CXCR4.
CXCR4 is a lipid raft-recruitable receptor that is exploited
by P. gingivalis for inhibiting TLR2-mediated innate immune
defense (7). In this paper, we have localized the CXCR4-
binding activity of P. gingivalis fimbriae to its FimCDE acces-
sory components. In terms of biological significance, P. gingi-
valis expressing FimCDE-deficient fimbriae is unable to exploit
CXCR4 in vivo and is eliminated relatively easily by the mouse
host compared to the wild-type strain. Our binding studies
have revealed modest-to-weak interactions between CXCR4
and the accessory proteins in the order FimC  FimD 
FimE, with the latter being completely inert. Strikingly, how-
ever, FimC in the presence of equimolar concentrations of
FIG. 6. Binding of fimbrial accessory proteins to extracellular matrix proteins. Binding of the indicated His-tagged fimbrial proteins to plates
coated with fibronectin (A) or type I collagen (B) was determined colorimetrically after probing with anti-His tag antibody. The horizontal dashed
lines indicate the average background binding of the fimbrial proteins to BSA-coated wells (OD450, 0.26 
 0.05). Data are means 
 standard
deviations (n 	 3), and asterisks show significant (P  0.05) binding compared to background values.
FIG. 7. Binding of FimC and FimD to immobilized FimE. Microtiter plates were coated with FimE, followed by addition of BSA (sham ligand),
FimC, FimD, or FimC plus FimD. The ligands were used at the indicated concentrations, except for BSA, for which the lower concentrations were
not used (NU). Binding was determined colorimetrically after probing with specific antibodies to FimC (A) or FimD (B). Background binding of
FimC or FimD to BSA-coated wells was negligible, representing 9% of specific binding values. Data are means 
 standard deviations (n 	 3),
and asterisks indicate significant (P  0.05) differences compared to the sham ligand control. Inverted triangles show significantly (P  0.05)
reduced binding compared to binding when a single ligand was added in the wells.
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FimD and FimE bound strongly to CXCR4, suggesting that
FimCDE may cooperate to form a functional complex with
enhanced binding properties over the individual molecules.
These data, and those from the matrix protein binding exper-
iments, also suggest that the likely role of FimE is not for direct
interactions with host molecules but for recruitment of FimC
and FimD into a functional complex associated with the FimA
fimbriae. Consistent with this notion, genetic inactivation of
fimE does not prevent the expression of fimC or fimD, but the
products of these genes are released into the culture medium
and are not associated with FimA fimbriae in the absence of
FimE (15). Furthermore, we have shown that FimE interacts
directly with FimC and FimD. The stoichiometry of this puta-
tive complex and its localization on the fimbrial structure—at
the tip of the fimbrial rod and/or elsewhere—has yet to be
determined. However, incorporation of quantitatively minor
accessory components into other, unrelated types of fimbriae
and their contribution as tip adhesive elements have previously
been demonstrated for Escherichia coli (9, 10).
In general, it is difficult to exclude the possibility that LPS in
bacterial protein samples may contribute to the results ob-
served. However, it is unlikely that this could be the case in our
study. Indeed, all three recombinant proteins (FimC, FimD,
and FimE) were purified using the same protocol and similarly
contained negligible endotoxic activity (8 EU/mg protein).
Most importantly, one of them (FimE) was completely inert in
binding host proteins or inducing a functional cellular re-
sponse. Therefore, LPS can be ruled out in terms of mediating
or contributing to any of the activities observed. In addition, we
noticed a synergistic effect in the binding and activation of
CXCR4 when all three proteins were allowed to interact with
the receptor, an effect that could not be interpreted by the
additive effect of having more LPS (even at the trace amounts
at which it could be detected) in the assay. On the other hand,
the synergistic effect can be readily explained by cooperative
interactions of the fimbrial proteins.
In a recent publication, we also showed that wild-type but
not FimCDE-deficient P. gingivalis interacts with complement
receptor 3 (CR3), a 2 integrin with pattern recognition ca-
pacity (24). However, in contrast to our results with CXCR4
and extracellular matrix proteins, we could not demonstrate
direct CR3 binding of any of the accessory proteins, tested
either alone or in combinations (unpublished observations).
This suggests that FimCDE-deficient fimbriae exhibit confor-
mational differences relative to wild-type fimbriae and may
thereby lack a structural pattern that is recognizable by CR3.
Our current data provide an explanation for our earlier
findings that FimCDE-deficient P. gingivalis is relatively avir-
ulent compared to the wild-type organism in the oral gavage
model of murine periodontitis (24). The poor virulence of the
FimCDE-deficient (DAP) mutants may now be attributed, at
least in part, to their inability to exploit CXCR4. Indeed, the
observation that the CXCR4 antagonist influences the persis-
tence of the wild-type strain but has no effect on the FimCDE-
deficient mutant examined (OZ5001C) indicates that the dif-
ferential persistence of the two strains is likely attributed to
different innate immune interactions, rather than possible dif-
ferences in in vivo growth. In fact, both strains exhibit similar
growth rates in vitro, although this cannot be reliably tested in
vivo, where any potential for growth will be influenced by the
host immune system. Additionally, colonization of periodontal
tissues is a prerequisite for induction of bone loss and the lack
of FimCDE expression may impair interactions of mutant P.
gingivalis with matrix proteins, resulting in reduced coloniza-
tion and virulence. We have previously used another FimCDE-
deficient mutant (KO4) which contains a nonpolar mutation in
fimE. This mutant expresses FimC and FimD, which cannot,
however, associate with fimbriae in the absence of FimE and
are thus secreted in the culture medium (15). On the other
hand, OZ5001C contains an insertional inactivation of fimC
which abrogates expression of FimCDE due to concomitant
polar effects on the downstream fimD and fimE genes (15). As
a consequence, KO4 and OZ5001C are phenotypically similar
in that they express FimA lacking all three accessory proteins
(i.e., DAP fimbriae) and display similar fimbrial structures
under electron microscopic examination (24). Most impor-
tantly, both strains behave in the exact same way in adherence
and phagocytic assays, susceptibility to phagocyte killing,
proinflammatory activities, and in vivo virulence (24). Thus,
regardless of whether expression of DAP fimbriae is due to
polar or nonpolar effects, the behavior of the mutant strains is
exactly the same, and consequently the strain used in the
present study (OZ5001C) is a genuinely representative DAP
strain.
In conclusion, we have shown that the FimCDE accessory
proteins display unique properties that enrich the virulence
repertoire of P. gingivalis fimbriae. Whereas FimC and FimD
display direct binding to exploited innate immune (CXCR4) or
matrix proteins (fibronectin and collagen), FimE is inert in that
regard. However, FimE may act as an adaptor protein which
integrates the FimCDE components into functional units of
enhanced activity over that of the individual components.
Thus, although the biological roles of the fimbrial accessory
proteins have remained obscure until recently, the newly at-
tributed virulence properties render FimCDE novel targets for
molecular intervention against P. gingivalis infections.
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